Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $130,351 - $145,058
-565 Reduced 38.49%
903 $220,000
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $93,628 - $103,577
-427 Reduced 22.53%
1,468 $355,000
Q4 2021

Feb 28, 2022

BUY
$198.88 - $227.6 $376,877 - $431,302
1,895 New
1,895 $426,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Echo45 Advisors LLC Portfolio

Follow Echo45 Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo45 Advisors LLC with notifications on news.